Lubrisine Eye Drops Recalled

On December 31, 2018, the FDA recalled Lubrisine Eye Drops after discovering the drops contained undeclared colloidal silver. The FDA also found that Results RNA LLC, the manufacturer of Lubrisine Eye Drops, was using manufacturing practices that do not support sterility.

Exposure to colloidal silver can result in permanent discoloration of the conjunctiva or the mucous membrane that covers the front of the eyeball and lines the eyelids. In addition, using non-sterile eye drops could lead to a potentially sight-threatening eye infection.

The product is used to lubricate dry eyes. No adverse events have yet been reported from this recall. The affected products are:

  • All lots manufactured from Mary 12, 2012 forward
  • UPC code 9238230723
  • Packaged in a single 1 oz. dropper bottle

If you or a loved one experienced discoloration in your eye and/or an eye infection after using Lubrisine Eye Drops, contact GoldenbergLaw.


We Truly Care

The GoldenbergLaw Difference
  • Kindness Is Strength.

    With us, you matter most. This team spends the time to ensure clients like you get to rest and leave the sleepless nights to us.

  • Accountability Is Bravery.

    We live and breathe what we do, and we don't stop until the responsible party is held liable.

  • Leadership Is Trust.

    Our firm has been trusted to lead roles within some of the nation's largest litigations.

  • Knowledge Is Power.

    Our firm is focused on the science of the case and applying it to helping our clients recover.

Contact Us

We Focus On What You Need
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.